A randomized phase III trial of IV carboplatin and paclitaxel × 3 courses followed by observation versus weekly maintenance low-dose paclitaxel in patients with early-stage ovarian carcinoma: A Gynecologic Oncology Group Study

This publication has 27 references indexed in Scilit:

• Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
  Journal of Clinical Oncology, 2009
• Genomic analysis of epithelial ovarian cancer
  Cell Research, 2008
• Pathogenesis of Ovarian Cancer
  International Journal of Gynecological Pathology, 2008
• Gene Expression Profiles of Serous, Endometrioid, and Clear Cell Subtypes of Ovarian and Endometrial Cancer
  Clinical Cancer Research, 2005
• Adjuvant Treatment for Early Ovarian Cancer: A Randomized Phase III Trial of Intraperitoneal ³²P or Intravenous Cyclophosphamide and Cisplatin—A Gynecologic Oncology Group Study
  Journal of Clinical Oncology, 2003
• Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
  Journal of Clinical Oncology, 2003
• Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial
  Journal of Clinical Oncology, 2003
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Randomized trial comparing cisplatin with radioactive phosphorus or whole-abdomen irradiation as adjuvant treatment of Ovarian cancer
  Cancer, 1992
• Adjuvant Therapy in Stage I and Stage II Epithelial Ovarian Cancer
  New England Journal of Medicine, 1990